What to Expect at a First NK Cell Therapy Consultation in Osaka

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

If you are considering NK cell therapy in Japan, the first consultation is where general information becomes a personal medical discussion. For international patients, it can feel unfamiliar: the health system is different, the therapy is offered outside national insurance, and you may be arranging everything from another country. This article explains what a first consultation at Grand Green Osaka Umekita Clinic in Osaka (Umeda) typically aims to cover, how you can prepare, and what a consultation cannot promise.

Why the first consultation matters

NK (natural killer) cells are innate immune cells that circulate in the blood and can recognize and attack abnormal cells, including cancer cells and virus-infected cells. NK cell therapy is a cancer immune cell therapy in which a patient’s own NK cells are obtained from a blood draw, activated and expanded at a specialized cell processing facility, and then returned by intravenous infusion. The aim is to support immune function, not to replace the cancer care you already receive.

Because every person’s diagnosis, treatment history, and general health are different, a website or an article cannot tell you whether this therapy is appropriate for you. The consultation is where a physician reviews your situation, explains what the therapy can and cannot be expected to do, and answers your questions. Nothing is decided simply by asking for an appointment, and you are free to take time to think before choosing to proceed.

What a doctor usually wants to understand

In general, a physician will want a clear picture of your cancer history before discussing any immune cell therapy. This often includes the type and stage of the cancer, when it was diagnosed, the treatments you have already had or are currently receiving, and how you have responded to them. Your overall condition, other medical conditions, medications, and allergies are also relevant, because they influence what is reasonable to consider and how safely a treatment can be given.

The doctor will also ask about your goals. Some people are looking for a treatment to use alongside surgery, chemotherapy, or radiation therapy. Others have completed standard treatment and want to discuss options with the aim of supporting immune function or because they are concerned about recurrence. Being open about your expectations helps the doctor explain the therapy in terms that match your actual situation, including its limits.

Records and information worth preparing

Good preparation makes a consultation more useful, especially when time is limited. Many international patients find it helpful to gather the following before the appointment:

• A summary or letter from your oncologist describing your diagnosis and treatment plan
• Recent pathology reports, imaging reports, and blood test results
• A list of current medications and supplements, including doses
• Details of past surgery, chemotherapy, radiation therapy, or other treatments, with dates
• Your passport and any contact details for your home physician

If your records are not in English or Japanese, ask the clinic in advance what format is acceptable, and whether a translated summary would help. It is also reasonable to write down your questions beforehand. Feeling rushed in an unfamiliar setting is common, and a short written list helps you leave with the answers you need.

Questions to ask about the therapy itself

A consultation is a two-way conversation. You may want to ask how the treatment would be scheduled, how many infusions are typically planned, and how long the whole course might take. Ask how your blood is collected, how the cells are processed, and how the infusion is carried out on an outpatient basis. Ask what side effects can occur, such as temporary fever or fatigue, what is monitored afterwards, and whom you should contact if something seems wrong once you are home.

It is equally important to ask about limits. Ask what evidence supports the therapy for your situation, what outcomes cannot be guaranteed, and in which circumstances the doctor would advise against it. Reliable answers will acknowledge uncertainty. Be cautious about any explanation that sounds like a promise of cure, because no cancer treatment can offer that, and immune cell therapy is not a substitute for standard treatment.

Cost, legal framework, and informed consent

In Japan, NK cell therapy is provided as a self-pay treatment, which means it is not covered by national health insurance, and it is delivered under the Act on the Safety of Regenerative Medicine. Under this framework, a treatment plan is submitted to and accepted by the authorities, and cell processing is carried out at licensed facilities. For you, the practical meaning is that the clinic can explain the plan, the facility involved, and the safety arrangements in a structured way.

Costs, the number of treatments, risks, side effects, and whether you are suitable all need to be confirmed with the doctor at your consultation. Ask for written explanations of fees and of what is included, and check the clinic’s fee information page as well. You should not feel pressured to decide on the day. Informed consent means that you understand the purpose, the possible benefits, the risks, and the alternatives, including continuing with standard treatment, before you agree to anything.

Coordinating with your home doctor and planning the trip

NK cell therapy is generally described as something that can be considered alongside standard cancer treatment, and the clinic can coordinate with the medical institution that provides your standard care. It helps to tell your home oncologist that you are exploring this option, and to ask them to share records or a referral summary. Open communication reduces the chance of conflicting advice and keeps everyone who cares for you informed.

Grand Green Osaka Umekita Clinic is located in the Umeda area of Osaka, which is easy to reach by train, and it offers information pages for international patients in several languages. Treatment is outpatient, involving a blood draw and an intravenous infusion without hospital admission, but your own schedule and travel plans should be discussed with the clinic. Whether or not you eventually choose this therapy, a clear first conversation with a physician is the safest way to decide what is right for you.

1. 1Gather your recordsReports and test results
2. 2Write your questionsIncluding limits and risks
3. 3Consult a physicianFit is decided by your doctor
4. 4Coordinate with home careShare plans with your oncologist

This diagram is a conceptual summary of the article content

References

• PubMed: Natural killer cell-based immunotherapy for cancer. (2025)
• PubMed: CAR-NK cells: A promising cellular immunotherapy for cancer. (2020)
• PubMed: Efficacy and safety of allogeneic CD19 CAR NK-cell therapy in systemic lupus erythematosus: a case series in China. (2026)
• PubMed: Emerging trends in clinical allogeneic CAR cell therapy. (2025)
• PubMed: Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity. (2018)
• MHLW (Japan): Regenerative Medicine — Ministry of Health, Labour and Welfare, Japan

Supervising Physician

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.